Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 35Colonic Neoplasms 14Colorectal Neoplasms 13Rectal Neoplasms 11Prostatic Neoplasms 11Neoplasms 10Carcinoma, Non-Small-Cell Lung 9Endometrial Neoplasms 8Uterine Cervical Neoplasms 7Obesity 7Motor Activity 7Lung Neoplasms 7Overweight 6Depression 6Small Cell Lung Carcinoma 5Ovarian Neoplasms 5Fatigue 5Breast Carcinoma In Situ 5Anxiety Disorders 5Tobacco Use Disorder 4Sexuality 4Sexual Dysfunction, Physiological 4Pancreatic Neoplasms 4Leukemia, Myeloid, Acute 4Carcinoma, Intraductal, Noninfiltrating 4Urinary Bladder Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Carcinoma, Renal Cell 3Carcinoma, Ovarian Epithelial 3

Interventions

Exercise 10Diet 5Caloric Restriction 5Nutrition Assessment 4Metformin 4Octreotide 3Megestrol Acetate 3Cognitive Behavioral Therapy 3anamorelin 2Standard of Care 2Olanzapine 2Mirtazapine 2Melatonin 2Liraglutide 2Eicosapentaenoic Acid 2Diet, Carbohydrate-Restricted 2Diet Therapy 2sibutramine 1remune 1olanzapine-fluoxetine combination 1lime 1irinotecan sucrosofate 1bermekimab 1Weight Reduction Programs 1Tirzepatide 1TOPS 1Surveys and Questionnaires 1Sugars 1Sampling Studies 1Ritonavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Weight Loss × Counseling × Clear all
NCT07219706 2026-03-13

FIBER+TRE

University of Oklahoma

Phase NA Recruiting
90 enrolled

Intermittent Fasting, Fasting, Feeding Behavior, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡